BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36512648)

  • 1. Exosomal miR-655-3p inhibits growth, and invasion and macrophage M2 polarization through targeting CXCR4 in papillary thyroid carcinoma.
    Qiao L; Dong C; Jia W; Ma B
    Acta Biochim Pol; 2022 Dec; 69(4):773-779. PubMed ID: 36512648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.
    Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y
    Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic papillary thyroid carcinoma cells-secreted exosomes deliver miR-221-3p to normoxic tumor cells to elicit a pro-tumoral effect by regulating the ZFAND5.
    Yu F; Deng X; Zhong Y; Guo B; Zhang X; Wu B
    Exp Cell Res; 2023 Oct; 431(1):113716. PubMed ID: 37488006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1.
    Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y
    Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization.
    Gao Y; Pan Y; Wang T; Yao Y; Yuan W; Zhu X; Wang K
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1650-1661. PubMed ID: 34687203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
    Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
    Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
    Bai X; Xu Y; Liu Y
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
    Cai J; Qiao B; Gao N; Lin N; He W
    Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
    Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-222-3p promotes the proliferation, migration and invasion of papillary thyroid carcinoma cells through targeting SLC4A4.
    Zhang C; Chang Q; Hu Y; Chang W; Guo X; Fu L; Tang G; Chen C
    Histol Histopathol; 2021 Nov; 36(11):1199-1207. PubMed ID: 34708859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
    Wang Y; Xu J; Zhu X; Kuang H
    Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
    Bi CL; Zhang YQ; Li B; Guo M; Fu YL
    J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p.
    Chen Y; Li Y; Gao H
    Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
    Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis.
    Du YL; Liang Y; Cao Y; Liu L; Li J; Shi GQ
    Biochem Genet; 2021 Apr; 59(2):437-452. PubMed ID: 33057875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling.
    Jiang Y; Liu Y; Zhang Y; Ouyang J; Feng Y; Li S; Wang J; Zhang C; Tan L; Zhong J; Zou L
    Cell Signal; 2023 Sep; 109():110792. PubMed ID: 37406787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma.
    Kong W; Yang L; Li PP; Kong QQ; Wang HY; Han GX; Wang QB
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3804-3811. PubMed ID: 29949156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ-LDLRAD3/miR-655-3p/MAPK1 axis enhances cell migration and invasion in papillary thyroid carcinoma.
    Zhang B; Peng Y; Zhou L
    Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):150-155. PubMed ID: 38430029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
    Sun Y; Zhang L; Zhang S
    Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.